Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Investigations – page 2

  • 79 clinical trials
  • 28 recruiting
  • 93 conditions
  • 21 countries

Conditions in this area

93 conditions with trials, the busiest first

Drug level12Human epidermal growth factor receptor negative8Fallopian tube cancer6Peritoneal cancer index6Breast cancer5Hormone receptor positive breast cancer5Allergy test4Allergy test positive3BRAF V600E mutation positive3Breast cancer female3Breast cancer metastatic3Hormone receptor positive HER2 negative breast cancer3Magnetic resonance imaging3Ovarian cancer recurrent3Colonoscopy2Cortisol abnormal2Hepatitis B e antigen negative2Hepatitis B virus test2Hypersensitivity2Infertility2Infertility female2Infertility tests normal2Non-small cell lung cancer stage IV2Ovarian cancer2+69

Clinical trials in Investigations

79 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

79 clinical trials

Congenital hypotransferrinaemia+5

Recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Human Apotransferrin
  • Sponsor:Prothya Biosolutions Netherlands B.V.

Cytomegalovirus test

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Valganciclovir
  • Sponsor:Centre Hospitalier Universitaire Rouen

BRAF V600E mutation positive+1

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cobicistat
  • Sponsor:Fore Biotherapeutics Inc.

Hypoxia+2

Recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:65+ years
  • Substances:Oxygen
  • Sponsor:Medical University Of Graz

Colonoscopy

Recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Aalborg University Hospital

Hyperadrenocorticism+1

Recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Metyrapone
  • Sponsor:Helse Bergen HF

Catatonia+1

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Oxybate
  • Sponsor:Amsterdam UMC

Breast cancer metastatic+2

Recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Elacestrant
  • Sponsor:Ellipses Pharma Limited

HIV infection+1

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Darunavir
  • Sponsor:Inserm

Papilloma viral infection+1

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Ciclosporin A
  • Sponsor:Labo'Life Belgium

Epstein-Barr virus infection reactivation+3

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Interferon Alfa
  • Sponsor:Labo'Life Belgium

Study on Ureter Imaging with Nizaracianine Triflutate for Patients 18+ Undergoing Abdominopelvic Surgery

Recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Curadel Surgical Innovations B.V.

Substances studied in this area

The therapies tested most often in Investigations trials.

Sodium Chloride11 clinical trialsPaclitaxel6 clinical trialsHistamine Dihydrochloride5 clinical trialsPembrolizumab4 clinical trialsAbemaciclib3 clinical trialsCapecitabine3 clinical trialsCarboplatin3 clinical trialsDoxorubicin Hydrochloride3 clinical trialsGadobutrol3 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.